Principal Securities’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-213
Closed -$5.3K 2956
2025
Q3
$5.3K Sell
213
-2
-0.9% -$43 ﹤0.01% 2945
2025
Q2
$4.95K Buy
215
+1
+0.5% +$23 ﹤0.01% 2876
2025
Q1
$4.18K Hold
214
﹤0.01% 2834
2024
Q4
$4.18K Buy
214
+53
+33% +$1.05K ﹤0.01% 2831
2024
Q3
$2.93K Sell
161
-472
-75% -$9.01K ﹤0.01% 2838
2024
Q2
$11K Sell
633
-24
-4% -$425 ﹤0.01% 2342
2024
Q1
$12.9K Sell
657
-181
-22% -$3.82K ﹤0.01% 2217
2023
Q4
$19.3K Buy
+838
New +$18.8K ﹤0.01% 1936

Other funds holding PRVA

Principal Securities's PRVA Position: Q4 2025 in Review

Principal Securities sold out of Privia Health (PRVA) in Q4 2025, closing a stake of 213 shares — an estimated $5.3K sold.

Principal Securities first reported a position in PRVA in Q4 2023 and held it in 8 quarters. The position peaked at $19.3K in Q4 2023. 276 funds tracked by Wall St. Rank hold PRVA as of Q4 2025.

  • Principal Securities reported no remaining Privia Health position as of Q4 2025 after selling out during the quarter.
  • Principal Securities sold 213 Privia Health shares in Q4 2025, an estimated $5.3K.
  • Principal Securities first reported a position in Privia Health in Q4 2023 and held it in 8 quarters.
  • Principal Securities's Privia Health position peaked at $19.3K in Q4 2023.
  • 276 funds tracked by Wall St. Rank held Privia Health as of Q4 2025.

Based on Principal Securities's 13F filing for Q4 2025, filed 12 Feb 2026.